Insiders Perspective Therapeutics, Inc.

Stocks

CATX

US46489V3024

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 15:59:51 2026-08-18 EDT			5-day change	1st Jan Change
3.210 ^USD	-0.31%		+0.47%	+16.18%

08-14	BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6	MT
08-11	Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says	MT

Insiders

07-08	Perspective Therapeutics, Inc. Announces Executive Changes	CI
25-09-04	Perspective Therapeutics Names Joel Sendek as CFO	MT
25-09-04	Perspective Therapeutics appoints biotech veteran Joel Sendek as chief financial officer	RE
25-09-04	Perspective Therapeutics appoints biotech veteran Joel Sendek as chief financial officer	RE
25-09-03	Perspective Therapeutics, Inc. Appoints Maya Martinez-Davis to Board of Directors and as A Member of the Compensation Committee of the Board and the Nominations Committee, Effective September 03, 2025	CI
25-01-06	Perspective Therapeutics Appoints Juan Graham as CFO; Shares Fall	MT
24-08-19	Perspective Therapeutics, Inc. Announces Executive Changes	CI
23-08-11	Perspective Therapeutics, Inc. Appoints Shane Cobb as Executive Vice President of Operations	CI
23-07-14	Perspective Therapeutics, Inc. Announces Termination of Jennifer Streeter as Chief Operating Officer	CI
23-05-15	Perspective Therapeutics, Inc. Announces Changes to the Board of Directors	CI
23-04-03	Perspective Therapeutics, Inc. Appoints Andrew Bright as Executive Vice-President of Brachytherapy	CI
23-02-10	Isoray, Inc. Announces Termination of William Cavanagh III as Chief Research and Development Officer	CI
23-02-06	Isoray, Inc. Announces Management Changes	CI
23-02-06	Isoray, Inc. Announces Executive Changes	CI
22-09-28	Isoray, Inc. Announces CEO Changes	CI
22-09-28	Isoray, Inc. to Appoint Board of Directors	CI
21-03-05	Michael Krachon to Resign as Executive Vice President of Sales and Marketing of Isoray, Effective March 12, 2021	CI
21-02-16	Isoray, Inc. Appoints Lisa Lauer as Vice President Business Development	CI
20-06-26	IsoRay, Inc. Announces Executive Changes	CI
19-07-24	IsoRay, Inc. Appoints Jennifer Streeter as Interim Chief Operating Officer	CI
19-02-19	Isoray, Inc. Announces Executive Changes	CI
18-12-17	IsoRay, Inc. Announces the Appointment of Lori Woods as Chief Executive Officer	CI
18-06-05	IsoRay, Inc. Announces Management Changes	CI
17-07-07	Isoray Announces Appointment of Mark Austin as Controller, Principal Accounting and Financial Officer, Effective July 24, 2017	CI
17-06-23	IsoRay, Inc Announces the Resignation of Matthew P. Branson as Controller, Principal Financial and Accounting Officer	CI